Company / Profit Margin
Vir Biotechnology, Inc. Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-638.9%
FY2025
5-year range
-2159.0% / -391.1%
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#124 of 146
Health Care
What the data says
Vir Biotechnology, Inc.'s profit margin of -638.9% is lower than 85% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 7 years, ranging from -2159.0% in FY2021 to -391.1% in FY2022.
Based on SEC 10-K filings.
-638.9% in FY2025 with a 5-year CAGR of -247.8%.
Improved from -713.7% to -638.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -247.8pp
- 5-Year Change
- -247.8pp
- 10-Year Change
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 146This company -638.9% Sector average -796.3%
▼
+19.8% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 9.2% year-over-year.
- Currently 157.4pp above the Health Care sector average.
- Peak profit margin was recorded in FY2022.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -638.9% | +9.2% |
| FY2024 | -703.4% | +1.4% |
| FY2023 | -713.7% | -82.5% |
| FY2022 | -391.1% | +81.9% |
| FY2021 | -2159.0% | -452.0% |
| FY2020 | -391.1% | +81.9% |
| FY2019 | -2159.0% | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026